{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:16:48Z","timestamp":1765041408158,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007828","1K01 HL147723","K23 HL123341"],"award-info":[{"award-number":["T32 HL007828","1K01 HL147723","K23 HL123341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Phenotypes and mechanisms of cardiovascular disease (CVD) may differ across global populations. In sub-Saharan Africa (SSA), distinct environmental determinants may influence development and progression of atherosclerotic coronary artery disease (CAD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We investigated associations between 6 established markers of myocardial stress and subsequent subclinical CAD (sCAD), defined as presence of any atherosclerosis on coronary CT angiography (CCTA) in a 2-year prospective cohort of Ugandan adults enriched for cardiometabolic risk factors (RFs) and HIV. Six plasma biomarkers were measured baseline among 200 participants (50% with HIV) aged\u2009<jats:underline>\u2265<\/jats:underline>\u200945 years with <jats:underline>\u2265<\/jats:underline>\u20091 cardiovascular RF. At 2-year follow-up, 132 participants (52% with HIV) who returned underwent coronary CCTA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In logistic regression models adjusted for cardiovascular RFs (age, diabetes, hypertension, hyperlipidemia, smoking, obesity) and non-traditional RFs (HIV, chronic kidney disease), only NT-proBNP predicted subsequent subclinical CAD (p\u2009&lt;\u20090.008, Bonferroni correction for multiple testing). In sensitivity analyses adjusted for ASCVD risk category (instead of individual RFs) in the baseline cohort with multiple imputation applied to missing year 2 CCTA data (n\u2009=\u2009200), NT-proBNP remained significantly associated with subsequent CAD (p\u2009&lt;\u20090.008).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>NT-proBNP consistently predicted subclinical CAD in Uganda in the absence of such an association among other markers of myocardial stress, suggesting a role for NT-proBNP in atherosclerosis independently of coronary microvascular dysfunction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-023-06385-0","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T14:02:30Z","timestamp":1687183350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating plasma NT-proBNP predicts subclinical coronary atherosclerosis on CT angiography among older adults in Uganda"],"prefix":"10.1186","volume":"16","author":[{"given":"Saate S","family":"Shakil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tecla M","family":"Temu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cissy","family":"Kityo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey Erem MBChB","family":"MMed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio S","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris T","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"1","key":"6385_CR1","doi-asserted-by":"publisher","first-page":"e001046","DOI":"10.1136\/openhrt-2019-001046","volume":"6","author":"B Alencherry","year":"2019","unstructured":"Alencherry B, Erem G, Mirembe G, et al. Coronary artery calcium, HIV and inflammation in Uganda compared with the USA. Open Heart. 2019;6(1):e001046. https:\/\/doi.org\/10.1136\/openhrt-2019-001046.","journal-title":"Open Heart"},{"key":"6385_CR2","doi-asserted-by":"publisher","first-page":"e009046","DOI":"10.1161\/CIRCOUTCOMES.122.009046","volume":"13","author":"SS Shakil","year":"2022","unstructured":"Shakil SS, Ojji D, Longenecker CT, Roth GA. Early stage and established hypertension in Sub-Saharan Africa: results from Population Health surveys in 17 countries, 2010\u20132017. Circ Cardiovasc qual outcomes. Published online October. 2022;13:e009046. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.122.009046.","journal-title":"Published online October"},{"issue":"2","key":"6385_CR3","doi-asserted-by":"publisher","first-page":"e064275","DOI":"10.1136\/bmjopen-2022-064275","volume":"13","author":"P Otieno","year":"2023","unstructured":"Otieno P, Asiki G, Wekesah F, et al. Multimorbidity of cardiometabolic diseases: a cross-sectional study of patterns, clusters and associated risk factors in sub-saharan Africa. BMJ Open. 2023;13(2):e064275. https:\/\/doi.org\/10.1136\/bmjopen-2022-064275.","journal-title":"BMJ Open"},{"key":"6385_CR4","doi-asserted-by":"publisher","unstructured":"Huaman MA, De Cecco CN, Bittencourt MS et al. Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda. Clinical Infectious Diseases. Published online January 3, 2021:ciaa1934. doi:https:\/\/doi.org\/10.1093\/cid\/ciaa1934.","DOI":"10.1093\/cid\/ciaa1934"},{"issue":"4","key":"6385_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/QAD.0000000000003451","volume":"37","author":"SS Shakil","year":"2023","unstructured":"Shakil SS, Temu TM, Kityo C, et al. Sex modulates the association between inflammation and coronary atherosclerosis among older ugandan adults with and without HIV. AIDS. 2023;37(4):579\u201386. https:\/\/doi.org\/10.1097\/QAD.0000000000003451.","journal-title":"AIDS"},{"issue":"11","key":"6385_CR6","doi-asserted-by":"publisher","first-page":"e018767","DOI":"10.1161\/JAHA.120.018767","volume":"10","author":"J Kipke","year":"2021","unstructured":"Kipke J, Margevicius S, Kityo C, et al. Sex, HIV Status, and measures of cardiac stress and fibrosis in Uganda. J Am Heart Association. 2021;10(11):e018767. https:\/\/doi.org\/10.1161\/JAHA.120.018767.","journal-title":"J Am Heart Association"},{"issue":"1","key":"6385_CR7","doi-asserted-by":"publisher","first-page":"e25868","DOI":"10.1002\/jia2.25868","volume":"25","author":"CT Longenecker","year":"2022","unstructured":"Longenecker CT, Bogorodskaya M, Margevicius S, et al. Sex modifies the association between HIV and coronary artery disease among older adults in Uganda. J Int AIDS Soc. 2022;25(1):e25868. https:\/\/doi.org\/10.1002\/jia2.25868.","journal-title":"J Int AIDS Soc"},{"issue":"B","key":"6385_CR8","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff","year":"2014","unstructured":"Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(B):2935\u201359. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.005. 25, Part.","journal-title":"J Am Coll Cardiol"},{"key":"6385_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ijcard.2016.11.054","volume":"228","author":"K Hirakawa","year":"2017","unstructured":"Hirakawa K, Yamamuro M, Uemura T, et al. Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis. Int J Cardiol. 2017;228:881\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.054.","journal-title":"Int J Cardiol"},{"issue":"12","key":"6385_CR10","doi-asserted-by":"publisher","first-page":"e0243213","DOI":"10.1371\/journal.pone.0243213","volume":"15","author":"E Jones","year":"2020","unstructured":"Jones E, Wei J, Nelson MD, et al. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: a report from the women\u2019s ischemia syndrome evaluation\u2013coronary vascular dysfunction (WISE-CVD) study. PLoS ONE. 2020;15(12):e0243213. https:\/\/doi.org\/10.1371\/journal.pone.0243213.","journal-title":"PLoS ONE"},{"issue":"3","key":"6385_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/QAD.0000000000000547","volume":"29","author":"S Dirajlal-Fargo","year":"2015","unstructured":"Dirajlal-Fargo S, Kinley B, Jiang Y, et al. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial. AIDS. 2015;29(3):313\u201321. https:\/\/doi.org\/10.1097\/QAD.0000000000000547.","journal-title":"AIDS"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-023-06385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-023-06385-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-023-06385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T14:06:36Z","timestamp":1687183596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-023-06385-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6385"],"URL":"https:\/\/doi.org\/10.1186\/s13104-023-06385-0","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CTL has received research grants from Gilead Sciences and Medtronic Foundation and has served on the board of Esperion Therapeutics. The other authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and approved by the Institutional Review Boards of University Hospitals Cleveland Medical Center, the Joint Clinical Research Centre (Kampala), and by the Uganda National Council for Science and Technology. All participants provided written informed consent. All study procedures were carried out in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"107"}}